15-34343662-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001284292.2(NUTM1):c.-35G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.149 in 1,533,972 control chromosomes in the GnomAD database, including 18,178 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.15 ( 1795 hom., cov: 32)
Exomes 𝑓: 0.15 ( 16383 hom. )
Consequence
NUTM1
NM_001284292.2 5_prime_UTR
NM_001284292.2 5_prime_UTR
Scores
14
Clinical Significance
Conservation
PhyloP100: -0.134
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0044864714).
BP6
Variant 15-34343662-G-C is Benign according to our data. Variant chr15-34343662-G-C is described in ClinVar as [Benign]. Clinvar id is 403246.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.316 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NUTM1 | NM_001284292.2 | c.-35G>C | 5_prime_UTR_variant | 1/8 | ENST00000537011.6 | NP_001271221.2 | ||
NUTM1 | NM_001284293.2 | c.30G>C | p.Lys10Asn | missense_variant | 1/7 | NP_001271222.2 | ||
NUTM1 | NM_175741.3 | c.-204G>C | 5_prime_UTR_variant | 1/8 | NP_786883.2 | |||
NUTM1 | XM_047432341.1 | c.-207G>C | 5_prime_UTR_variant | 1/8 | XP_047288297.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NUTM1 | ENST00000537011.6 | c.-35G>C | 5_prime_UTR_variant | 1/8 | 2 | NM_001284292.2 | ENSP00000444896 | A2 | ||
NUTM1 | ENST00000333756.5 | c.-204G>C | 5_prime_UTR_variant | 1/8 | 1 | ENSP00000329448 | P2 | |||
NUTM1 | ENST00000438749.7 | c.30G>C | p.Lys10Asn | missense_variant | 1/7 | 2 | ENSP00000407031 | A2 |
Frequencies
GnomAD3 genomes AF: 0.150 AC: 22775AN: 152102Hom.: 1793 Cov.: 32
GnomAD3 genomes
AF:
AC:
22775
AN:
152102
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.168 AC: 21590AN: 128342Hom.: 2039 AF XY: 0.170 AC XY: 11926AN XY: 70300
GnomAD3 exomes
AF:
AC:
21590
AN:
128342
Hom.:
AF XY:
AC XY:
11926
AN XY:
70300
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.149 AC: 206075AN: 1381752Hom.: 16383 Cov.: 29 AF XY: 0.151 AC XY: 102664AN XY: 681866
GnomAD4 exome
AF:
AC:
206075
AN:
1381752
Hom.:
Cov.:
29
AF XY:
AC XY:
102664
AN XY:
681866
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.150 AC: 22788AN: 152220Hom.: 1795 Cov.: 32 AF XY: 0.153 AC XY: 11424AN XY: 74434
GnomAD4 genome
AF:
AC:
22788
AN:
152220
Hom.:
Cov.:
32
AF XY:
AC XY:
11424
AN XY:
74434
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
502
ALSPAC
AF:
AC:
572
ExAC
AF:
AC:
2147
Asia WGS
AF:
AC:
772
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationTaster
Benign
P;P
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Vest4
MutPred
Loss of MoRF binding (P = 0.0167);
ClinPred
T
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at